In contrast, signaling in the IBD samples increased between CD4 and CD8 T cells, as well as from B cells to T cells (e.g. CLEC2C-KLRB1, HLA-B-CD8A, HLA-C-CD8A). This evidence concerns the gene CD4 and inflammatory bowel disease.